文献速递消化道肿瘤放疗放疗物理与技术

深度学习剂量预测加速直肠癌VMAT放疗计划

Dose prediction using a deep neural network for accelerated planning of rectal cancer radiotherapy.
PubMed 文献 · Radiother Oncol · 2020-05-19

本研究回顾性纳入187例直肠癌患者,应用DeepLabv3+深度神经网络预测VMAT剂量分布,并引入先验剂量信息辅助计划方案。预测结果临床可接受,MSE为0.001,平均δD为0.40%,信息辅助重计划最多节省15.76分钟。

要点

  • DeepLabv3+预测的直肠癌VMAT剂量分布均临床可接受
  • 以批准剂量为基准,MSE为0.001,平均δD为0.40%
  • 先验信息辅助重计划最多节省15.76分钟

核心结论

  • DeepLabv3+成功预测直肠癌剂量分布,预测的先验信息有助于不同经验水平剂量师节省计划时间。

研究设计与样本

  • 回顾性研究随机选取2018年2月至2019年4月治疗的187例直肠癌患者的CT扫描和批准的VMAT计划及Doseapproved。
  • 应用DeepLabv3+深度神经网络进行剂量分布预测,并引入先验剂量信息辅助计划方案。
  • 由1年和6年经验剂量师分别进行信息辅助和经验重计划,采用配对t检验和双因素方差分析评估。

主要发现

  • DeepLabv3+预测结果(DoseDeepLabv3+)均临床可接受。
  • 以Doseapproved为基线,MSE为0.001,平均δD为0.40%,四分位距为0.079%-0.30%。
  • 除适形指数外,Doseapproved与DoseDeepLabv3+的计划靶区定量参数无显著差异。
  • 双因素方差分析显示信息辅助与经验重计划间重计划时间有显著差异,最大节省15.76分钟。
  • 信息辅助重计划优势为更低最大剂量、更高最小剂量和更低均匀性指数,劣势为更低适形指数和更高机器跳数,差异显著。

临床怎么用

  • 可将DeepLabv3+剂量预测用于直肠癌VMAT计划加速,先验信息辅助可缩短重计划时间。
  • 信息辅助重计划可能改善剂量均匀性但需注意适形指数降低和机器跳数增加。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To apply a deep neural network to predict dose distributions of rectal cancer patients for accelerated volume modulated arc technique (VMAT) planning. MATERIALS AND METHODS: Computed tomography scans and approved VMAT plans together with Doseapproved of 187 patients treated from February 2018 to April 2019 were randomly selected for this retrospective study. The deep neural network DeepLabv3+ was applied for dose distribution prediction. A prior dose information-aided planning scheme was introduced. Prediction precision was evaluated by mean square error (MSE), normalized dose difference (δD), and dose-volume histogram (DVH) indices using a paired t test. Information-aided and experienced replanning were performed by 1-year and 6-year experienced dosimetrists, respectively. Replanning time and DVH indices were evaluated by two-way variance analysis. RESULTS: The DeepLabv3+ prediction results (DoseDeepLabv3+) were all clinically acceptable. Taking Doseapproved as the baseline, the MSE was 0.001 and mean δD was 0.40% with an inter-quartile range of 0.079%-0.30% for DoseDeepLabv3+. No significant differences were found for the planning target volume quantitative parameters between Doseapproved and DoseDeepLabv3+, except for the conformality index. For the two-way variance analysis, a significantly different replanning time was found between the information-aided and experienced replanning with maximum time-saving of 15.76 min. Information-aided replans had the advantage of lower maximum dose, higher minimum dose, and lower homogeneity index, and the disadvantage of lower conformality index and higher machine unites with significant differences. CONCLUSION: DeepLabv3+ successfully predicted rectal cancer dose distribution, and the predicted prior information helped save planning times for multi-level experienced dosimetrists.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Song Y, Hu J, Liu Y, et al. Dose prediction using a deep neural network for accelerated planning of rectal cancer radiotherapy. Radiother Oncol. 2020. PMID: 32416279. doi:10.1016/j.radonc.2020.05.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。